ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1568 • 2016 ACR/ARHP Annual Meeting

    Microrna-17 Suppresses TNF-α Signaling By Reducing TRAF2 and cIAP2 Association in Rheumatoid Arthritis Synovial Fibroblasts

    Nahid Akhtar1, Anil Singh2 and Salahuddin Ahmed1, 1Department of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA, 2Washington State University, College of Pharmacy, Spokane, WA

    Background/Purpose:   TNF-α is a major cytokine implicated in rheumatoid arthritis (RA) and its expression has shown to be regulated at transcriptional and posttranscriptional levels.…
  • Abstract Number: 1569 • 2016 ACR/ARHP Annual Meeting

    Increased Circulating CD14brightCD16+ Intermediate Monocytes Are Regulated By Interleukin-10 in Patients with Rheumatoid Arthritis

    Masako Tsukamoto1, Noriyuki Seta2, Keiko Yoshimoto1, Katsuya Suzuki1, Kunihiro Yamaoka1 and Tsutomu Takeuchi1, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 2Department of Internal Medicine, Tokyo Dental College, Ichikawa General Hospital, Chiba, Japan

    Background/Purpose:  The study enrolled 35 untreated RA patients and 14 healthy volunteers. DAS28-ESR was evaluated and peripheral blood samples were obtained at baseline and following…
  • Abstract Number: 1570 • 2016 ACR/ARHP Annual Meeting

    Working in Cold Environment Is Associated with Increased Risk of Developing Rheumatoid Arthritis: Results from a Swedish Population-Based Case-Control Study

    Pingling Zeng1, Lars Klareskog2, Camilla Bengtsson3 and Lars Alfredsson4, 1Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden, 3Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden, 4Section of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: To investigate whether working in cold environment is associated with an increased risk of developing rheumatoid arthritis (RA) (overall), anti-citrullinated protein antibody (ACPA)-positive RA…
  • Abstract Number: 1571 • 2016 ACR/ARHP Annual Meeting

    Altered Bioenergetics, Mitochondrial Function and Pro-Inflammatory Pathways in RA Synovium in Response to Tofacitinib

    Carl Orr1, Trudy McGarry2, Monika Biniecka3, Jennifer McCormick4, Ursula Fearon5 and Douglas J. Veale1, 1Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 2St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 3St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 4Department of Rheumatology, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 5Trinity College Dublin, Department of Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland

    Background/Purpose:  Rheumatoid arthritis (RA) is a chronic joint disease, characterised by synovial inflammation and destruction of articular cartilage/bone. The Janus-Kinase and Signal Transducer and Activator…
  • Abstract Number: 1572 • 2016 ACR/ARHP Annual Meeting

    Relationship Between KDR (VEGFR2) Gene Polymorphisms and Serum KDR Protein Levels in Patients with Rheumatoid Arthritis

    Agnieszka Paradowska-Gorycka1, Barbara Stypinska2, Andrzej Pawlik3, Damian Malinowski3, Katarzyna Romanowska-Próchnicka4, Ewa Haladyj5, Malgorzata Manczak6 and Marzena Olesinska7, 1Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland, 2Department of Biochemistry and Molecular Biology, National Institute of geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland, 3Department of Pharmacology, Pomeranian Medical University, Szczecin, Poland, 4Department of Pathophysiology, Medical University of Warsaw and Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland, 5Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland, 6Department of Epidemiology and Health Promotion, National Institute of geriatrics, Rheumatology and Rehabilitation,, Warsaw, Poland, 7Department of Connective Tissue Disease, National Institute of Geriatrics, Rheumatology and Rehabilitation,, Warsaw, Poland

    Background/Purpose:  Rheumatoid arthritis (RA) is one of the chronic autoimmune diseases, with genetic and environmental predisposition, and synovial angiogenesis is considered to be a notable…
  • Abstract Number: 1573 • 2016 ACR/ARHP Annual Meeting

    Major Histocompatibility Antigen HLA-DQ6.1 (DQA1*0103/DQB1*0601) Increases Rheumatoid Arthritis Risk Independent of Shared Epitope Among Indians

    Able Lawrence1, Swayam Prakash2, Uddalak Bharadwaj3, Amita Aggarwal4, Ramnath Misra4 and Suraksha Agrawal2, 1Clinical Immunology, SGPGIMS, Lucknow, India, 2Medical Genetics, SGPGIMS, Lucknow, India, 3MD Anderson Cancer Center, Houston, TX, 4Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: The association of HLA-DRB1 shared epitope (SE) with rheumatoid arthritis (RA) does not completely explain MHC association. The HLA-DRB1 alleles are classified into high…
  • Abstract Number: 1574 • 2016 ACR/ARHP Annual Meeting

    The Role of Shelterin Deficiency in the Senescence in T Cells of Rheumatoid Arthritis

    Wenjie Zheng1, Lili Zhang2, Hua Chen3 and Yan Zhao1, 1Rheumatology, Peking Union Medical College Hospital, Beijing, China, 2Infection and Immunity, Tianjin people's hospital, Tianjing, China, 3Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: T cells abnormality is an essential part in the pathogenesis of rheumatoid arthritis (RA), which includes a signature of premature immune aging, and restricted…
  • Abstract Number: 1575 • 2016 ACR/ARHP Annual Meeting

    Transient Circulatory Existence of Multipotential Stromal Cells Is Unlikely to Contribute to the Pathogenesis of Rheumatoid Arthritis

    Sarah Churchman1, Sally Boxall1, Elena Jones1, Paul Emery1, Peter Giannoudis1,2 and Dennis McGonagle1, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds,, Leeds, United Kingdom, 2Academic Department of Trauma and Orthopaedics, Leeds, United Kingdom

    Background/Purpose:  Circulating multipotential stromal cells (MSCs) also termed mesenchymal stem cells have previously been implicated in fibroblast mediated polyarticular joint destruction in rheumatoid arthritis (RA).…
  • Abstract Number: 1576 • 2016 ACR/ARHP Annual Meeting

    Identifying Rheumatoid Arthritis Subtypes Using Synovial Tissue Gene Expression Profiling, Histologic Scoring and Clinical Correlates

    Dana E. Orange1, Susan M. Goodman2, Phaedra Agius3, Ryan Cummings4, Kathleen Andersen1, Robert Darnell5, Lionel Ivashkiv2, Alessandra B. Pernis6, Edward F. DiCarlo7, Vivian P. Bykerk8 and Laura T. Donlin9, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Medicine, Hospital for Special Surgery, New York, NY, 3New York Genome Center, New York, NY, 4Hospital for Special Surgery, New York, NY, 5The New York Genome Center, New York, NY, 6David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 7Laboratory Medicine, Hospital for Special Surgery, New York, NY, 8Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 9Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: The histopathologic features of synovial tissue vary widely among patients with rheumatoid arthritis (RA) undergoing arthroplasty and the clinical significance of this variability is…
  • Abstract Number: 1577 • 2016 ACR/ARHP Annual Meeting

    An Investigation of Translocator Protein As a Tissue and Peripheral Blood Biomarker of Inflammation in Rheumatoid Arthritis

    Nehal Narayan1, Francesco Carlucci2 and Peter C. Taylor3, 1Rheumatology, University of Oxford, Oxford, United Kingdom, 2The Botnar Research Centre, University of Oxford, oxford, United Kingdom, 3Kennedy Institute of Rheumatology, Imperial College London, London, United Kingdom

    Background/Purpose: Translocator protein (TSPO) is a mitochondrial cholesterol transporter, utilised in diseases as a Positron Emission Tomography (PET) imaging marker of macrophage infiltration. Recent observations…
  • Abstract Number: 1578 • 2016 ACR/ARHP Annual Meeting

    Functional Screening of Micrornas Using the Inhibitor Library Identified Micrornas to Regulate Expression of MMP-3 and IL-6 in Rheumatoid Arthritis Synovial Fibroblasts

    Fumitaka Mizoguchi, Hisanori Hasegawa and Hitoshi Kohsaka, Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

    Background/Purpose: Synovial fibroblasts play crucial roles in the pathogenesis of rheumatoid arthritis (RA). They secrete proteinases and proinflammatory cytokines to damage the synovial tissues in…
  • Abstract Number: 1579 • 2016 ACR/ARHP Annual Meeting

    Small Rnaseq Reveals Different Plasma miRNA Signature in Patients with RA and SLE: A Pilot Study

    Michelle J. Ormseth1, Joseph F. Solus2, Yan Guo3, Quanhu Sheng3, Ryan Allen3, Kasey C. Vickers3 and C Michael Stein3, 1Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, 3Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: MicroRNAs (miRNAs) are ~22-nt RNAs that post-transcriptionally regulate gene expression and serve as biomarkers of many disease states. Most previous plasma miRNA studies in…
  • Abstract Number: 1580 • 2016 ACR/ARHP Annual Meeting

    Impact of Rituximab on Patient-Reported Outcomes in Patients with Rheumatoid Arthritis from the US Corrona Registry

    Leslie R Harrold1, Ani John2, Jennie Best2, Steve Zlotnick2, Chitra Karki3, YouFu Li4, Jeffrey D. Greenberg5 and Joel Kremer6, 1UMass Medical School, Worcester, MA, 2Genentech, Inc., South San Francisco, CA, 3Corrona, LLC, Southborough, MA, 4University of Massachusetts Medical School, Worcester, MA, 5New York University School of Medicine, New York, NY, 6The Center for Rheumatology, Albany Medical College, Albany, NY

    Background/Purpose: Patients with rheumatoid arthritis (RA) experience diminished quality of life and increased disability. Patient-reported outcomes (PROs) are important measures of response to therapy in…
  • Abstract Number: 1581 • 2016 ACR/ARHP Annual Meeting

    The Combination of IL-6 and IL-6 Receptor Levels As a Biomarker of Response to Tocilizumab in Rheumatoid Arthritis Patients

    Cesar Diaz-Torne1, Maria A. Ortiz2, Patricia Moya3, M. Victoria Hernández4, Delia Reina5, Ivan Castellvi6, Juan Jose De Agustin7, Diana De La Fuente8, Hector Corominas9,10, Raimon Sanmarti11, Josep Maria De Llobet Zubiaga1 and Silvia Vidal2, 1Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, 2Institut de Recerca Sant Pau, Barcelona, Spain, 3Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 4Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain, 5Rheumatology, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain, 6Rheumatology, Hospital de Sant Pau, Barcelona, Spain, 7Rheumatology, Hospital Baix de Llobregat, Barcelona, Spain, 8Rheumatology, Hospital de Viladecans, Barcelona, Spain, 9Rheumatology, Hospital Moises Broggi, Barcelona, Spain, 10Servei de Reumatologia, Hospital Moises Broggi, Barcelona, Spain, 11Arthritis Unit. Rheumatology, Arthritis Unit. Rheumatology Department. Hospital Clínic, Barcelona, Spain

    Background/Purpose: Several predictors of response to tocilizumab have been described.  They include a low HAQ, high baseline CRP or NK levels and certain IL-6R polymorphisms.…
  • Abstract Number: 1582 • 2016 ACR/ARHP Annual Meeting

    Assessment of Safety, Pharmacokinetics and Pharmacodynamics of a Novel Anti-CD40 Monoclonal Antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients

    Alan Slade1, Phillip Koo1, Yanling He2, Pascal Espie3, Anita Auger-Sarrazin3, James S. Rush3 and Peter Gergely3, 1Novartis Pharmaceuticals Corporation, East Hanover, NJ, 2Novartis Pharmaceuticals Corporation, Cambridge, MA, 3Novartis Pharmaceuticals Corporation, Basel, Switzerland

    Background/Purpose: Aberrant CD40-CD154 pathway signaling has been linked to pathology in autoimmune disease. Blocking the CD40-CD154 pathway prevents T cell-dependent antibody responses, germinal center formation…
  • « Previous Page
  • 1
  • …
  • 1520
  • 1521
  • 1522
  • 1523
  • 1524
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology